FDA Approved: LEQVIO — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA granted original approval for LEQVIO (inclisiran) from Novartis Pharmaceuticals Corporation. The drug lowers LDL cholesterol in adults with primary hyperlip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Mixed Dyslipidemia

Drugs mentioned

• LEQVIO (inclisiran)

Snippet

ORIG AP for LEQVIO (INCLISIRAN)